关注
Julian Lindsay
Julian Lindsay
Fred Hutchinson Cancer Center, National Centre for Infection in Cancer (NCIC)
在 fredhutch.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Structure, function and polymorphism of human cytosolic sulfotransferases
Y Li, J Lindsay, LL Wang, SF Zhou
Current drug metabolism 9 (2), 99-105, 2008
2032008
The development and evaluation of an oncological palliative care deprescribing guideline: the ‘OncPal deprescribing guideline’
J Lindsay, M Dooley, J Martin, M Fay, A Kearney, M Khatun, M Barras
Supportive care in cancer 23, 71-78, 2015
1692015
Reducing potentially inappropriate medications in palliative cancer patients: evidence to support deprescribing approaches
J Lindsay, M Dooley, J Martin, M Fay, A Kearney, M Barras
Supportive Care in Cancer 22, 1113-1119, 2014
912014
Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2021
BW Teh, DK Yeoh, GM Haeusler, CK Yannakou, S Fleming, J Lindsay, ...
Internal Medicine Journal 51, 67-88, 2021
572021
Azole antifungals and new targeted therapies for hematological malignancy
J Lindsay, BW Teh, K Micklethwaite, M Slavin
Current opinion in infectious diseases 32 (6), 538-545, 2019
572019
Serum levels, safety and tolerability of new formulation SUBA-itraconazole prophylaxis in patients with haematological malignancy or undergoing allogeneic stem cell transplantation
J Lindsay, I Sandaradura, K Wong, C Arthur, W Stevenson, I Kerridge, ...
Journal of Antimicrobial Chemotherapy 72 (12), 3414-3419, 2017
472017
Effects of food and omeprazole on a novel formulation of super bioavailability itraconazole in healthy subjects
J Lindsay, S Mudge, GR Thompson III
Antimicrobial agents and chemotherapy 62 (12), 10.1128/aac. 01723-18, 2018
342018
Epstein–Barr virus posttransplant lymphoproliferative disorder: update on management and outcomes
J Lindsay, J Othman, MR Heldman, MA Slavin
Current opinion in infectious diseases 34 (6), 635-645, 2021
252021
Epstein‐Barr virus related post‐transplant lymphoproliferative disorder prevention strategies in allogeneic hematopoietic stem cell transplantation
J Lindsay, MK Yong, M Greenwood, DCM Kong, SCA Chen, W Rawlinson, ...
Reviews in Medical Virology 30 (4), e2108, 2020
242020
Infection-related mortality in adults and children undergoing allogeneic hematopoietic cell transplantation: an Australian registry report
J Lindsay, I Kerridge, L Wilcox, S Tran, TA O'Brien, M Greenwood, ...
Transplantation and Cellular Therapy 27 (9), 798. e1-798. e10, 2021
212021
Safety, clinical effectiveness and trough plasma concentrations of intravenous posaconazole in patients with haematological malignancies and/or undergoing allogeneic …
W Jeong, P Haywood, N Shanmuganathan, J Lindsay, K Urbancic, ...
Journal of Antimicrobial Chemotherapy 71 (12), 3540-3547, 2016
212016
New advances in the management of cytomegalovirus in allogeneic haemopoietic stem cell transplantation
MK Yong, D Gottlieb, J Lindsay, J Kok, W Rawlinson, M Slavin, D Ritchie, ...
Internal medicine journal 50 (3), 277-284, 2020
152020
Epidemiology of complementary and alternative medicine therapy use in allogeneic hematopoietic stem cell transplant survivorship patients in Australia
J Lindsay, M Kabir, N Gilroy, G Dyer, L Brice, J Moore, M Greenwood, ...
Cancer Medicine 5 (12), 3606-3614, 2016
132016
Choice and duration of antifungal prophylaxis and treatment in high-risk haematology patients
J Coussement, J Lindsay, BW Teh, M Slavin
Current Opinion in Infectious Diseases 34 (4), 297-306, 2021
122021
Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation: Pre‐transplant predictors of survival, reactivation, and spontaneous clearance
J Lindsay, J Othman, I Kerridge, K Fay, W Stevenson, C Arthur, SCA Chen, ...
Transplant Infectious Disease 23 (3), e13548, 2021
112021
SUBA-itraconazole for primary antifungal prophylaxis after allogeneic hematopoietic cell transplantation
J Lindsay, J Othman, Y Kong, A Yip, S Van Hal, S Larsen, C Bryant, ...
Open Forum Infectious Diseases 8 (11), ofab502, 2021
92021
Facing the challenges of new melanoma-targeted therapies: treatment of severe fevers associated with dabrafenib/trametinib combination therapy
JN Lindsay, M Barras
Journal of Oncology Pharmacy Practice 21 (4), 293-295, 2015
72015
Voriconazole in hematopoietic stem cell transplantation and cellular therapies: Real-world usage and therapeutic level attainment at a major transplantation center
J Lindsay, EM Krantz, J Morris, A Sweet, F Tverdek, A Joshi, R Yeh, ...
Transplantation and Cellular Therapy 28 (8), 511. e1-511. e10, 2022
62022
Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter study
M Bhurani, L Admojo, C Van Der Weyden, R Twigger, A Bazargan, ...
Leukemia & lymphoma 62 (2), 330-336, 2021
62021
Subtherapeutic concentrations of posaconazole tablet: determining risk factors and effectiveness of a standardized dose adjustment in hematology inpatients
J Bui, R Gellatly, J Othman, J Lindsay
Leukemia & Lymphoma 63 (14), 3418-3425, 2022
42022
系统目前无法执行此操作,请稍后再试。
文章 1–20